This research aims to evaluate the effectiveness of a clinical decision support tool (CDST) in predicting remission rates in children with inflammatory bowel disease.
Utilized a clinical decision support tool to assess pediatric patients with inflammatory bowel disease.
Analyzed the predictive capacity of the CDST for week 52 remission rates.
Employed sensitivity analysis to determine cut points for remission prediction.
The CDST showed significant applicability for predicting week 52 remission in pediatric patients.
A CDST score greater than 19 demonstrated high sensitivity for predicting remission.
Abstract
The CDST appears to have applicability for predicting week 52 SFR in children with UC or CD. CDST score of >19 is a highly sensitive cut point for predicting SFR in our pediatric IBD patients.